Skip to main content

MoonLake Immunotherapeutics

MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001821586

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
27
−18 vs. Q4 2021
Shares held
11.6M
+141.4K (+1.2%) vs. Q4 2021
Total value
$123.4M
+$10.6M (+9.4%) vs. Q4 2021
New holders
7
8 more added
Sold out
25
2 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 27 institutions
Q1 2021: 42 institutionsQ2 2021: 46 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 27 institutionsQ2 2022: 23 institutionsQ3 2022: 24 institutionsQ4 2022: 33 institutionsQ1 2023: 43 institutionsQ2 2023: 83 institutionsQ3 2023: 118 institutionsQ4 2023: 125 institutionsQ1 2024: 114 institutionsQ2 2024: 111 institutionsQ3 2024: 109 institutionsQ4 2024: 116 institutionsQ1 2025: 136 institutionsQ2 2025: 130 institutionsQ3 2025: 134 institutionsQ4 2025: 130 institutionsQ1 2026: 147 institutionsQ2 2026: 172 institutions
Value heldQ1 2022: $123.4M
Q1 2021: $108.9MQ2 2021: $115.8MQ3 2021: $111.1MQ4 2021: $112.8MQ1 2022: $123.4MQ2 2022: $190.1MQ3 2022: $291.4MQ4 2022: $396.4MQ1 2023: $843.2MQ2 2023: $2.86BQ3 2023: $3.21BQ4 2023: $3.53BQ1 2024: $2.99BQ2 2024: $2.67BQ3 2024: $3.14BQ4 2024: $3.43BQ1 2025: $2.34BQ2 2025: $2.77BQ3 2025: $269.7MQ4 2025: $742.9MQ1 2026: $1.17BQ2 2026: $1.43B
Institutions holding MLTX and their total value by quarter
QuarterHoldersValue
Q2 2026172$1.43B
Q1 2026147$1.17B
Q4 2025130$742.9M
Q3 2025134$269.7M
Q2 2025130$2.77B
Q1 2025136$2.34B
Q4 2024116$3.43B
Q3 2024109$3.14B
Q2 2024111$2.67B
Q1 2024114$2.99B
Q4 2023125$3.53B
Q3 2023118$3.21B
Q2 202383$2.86B
Q1 202343$843.2M
Q4 202233$396.4M
Q3 202224$291.4M
Q2 202223$190.1M
Q1 202227$123.4M
Q4 202145$112.8M
Q3 202143$111.1M
Q2 202146$115.8M
Q1 202142$108.9M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2021.

Institutions holding MLTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Cormorant Asset Management, LP3,280,000$33.3M2.55%+2,850,000+662.8%Added
FMR LLC1,193,000$13.2M0.00%00.0%Unchanged
BlackRock Inc.741,906$8.24M0.00%00.0%Unchanged
683 Capital Management, LLC790,000$7.90M0.47%+200,000+33.9%Added
Citadel Advisors LLC698,896$7.76M0.01%+12,959+1.9%Added
Marshall Wace, LLP653,872$7.26M0.02%+120,968+22.7%Added
Staley Capital Advisers Inc580,000$6.35M0.32%00.0%Unchanged
Price T Rowe Associates Inc566,191$6.29M0.00%−180,671−24.2%Reduced
Beryl Capital Management LLC459,243$5.10M0.31%+459,243New
Falcon Edge Capital, LP448,882$4.49M0.40%+141,047+45.8%Added
Avidity Partners Management LP400,000$4.44M0.10%00.0%Unchanged
D. E. Shaw & Co., Inc.337,021$3.74M0.00%00.0%Unchanged
Tekla Capital Management LLC250,000$2.77M0.10%00.0%Unchanged
EcoR1 Capital, LLC200,000$2.22M0.07%00.0%Unchanged
Weiss Asset Management LP177,510$1.97M0.04%+162,510+1,083.4%Added
Iron Park Capital Partners, LP179,434$1.79M1.51%+117,218+188.4%Added
Millennium Management LLC148,225$1.65M0.00%+92,490+165.9%Added
Consonance Capital Management LP137,000$1.52M2.58%−13,000−8.7%Reduced
Jane Street Group, LLC65,437$726.0K0.00%+65,437New
Picton Mahoney Asset Management70,000$700.0K0.03%00.0%Unchanged
Fir Tree Capital Management LP61,866$619.0K0.02%+61,866New
Omers Administration Corp46,247$513.0K0.01%+46,247New
Meridian Wealth Management, LLC42,094$467.0K0.05%00.0%Unchanged
Nomura Holdings Inc22,733$239.0K0.00%00.0%Unchanged
Ergoteles LLC14,613$162.0K0.01%+14,613New
UBS Group AG1,692$19.0K0.00%+1,692New
Clear Street LLC801$9.00K0.00%+801New
Adage Capital Partners GP, L.L.C.0$00.00%−1,011,589−100.0%Sold out
Boxer Capital, LLC0$00.00%−400,000−100.0%Sold out
Octagon Capital Advisors LP0$00.00%−400,000−100.0%Sold out
Credit Suisse AG0$00.00%−371,849−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−320,000−100.0%Sold out
Altium Capital Management LP0$00.00%−250,000−100.0%Sold out
Tenor Capital Management Co., L.P.0$00.00%−201,152−100.0%Sold out
Cowen Investment Management LLC0$00.00%−200,000−100.0%Sold out
BlueCrest Capital Management Ltd0$00.00%−150,000−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−131,823−100.0%Sold out
Omni Event Management Ltd0$00.00%−100,913−100.0%Sold out
Cohen & Co Financial Management, LLC0$00.00%−100,000−100.0%Sold out
Jefferies Group LLC0$00.00%−78,308−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−50,106−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−50,000−100.0%Sold out
TD Asset Management Inc0$00.00%−44,766−100.0%Sold out
Magnetar Financial LLC0$00.00%−37,385−100.0%Sold out
Radcliffe Capital Management, L.P.0$00.00%−25,130−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−25,200−100.0%Sold out
Caxton Corp0$00.00%−16,009−100.0%Sold out
HRT Financial LP0$00.00%−14,258−100.0%Sold out
Rpo LLC0$00.00%−13,600−100.0%Sold out
Morgan Stanley0$00.00%−13,449−100.0%Sold out
Antara Capital LP0$00.00%−6,246−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−193−100.0%Sold out